ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

OBJECTIVE: We report the functional status and steroid dosing changes in a phase II clinical trial of bevacizumab and temozolomide for upfront treatment of patients with GBM and age ≥70. Evaluation of steroid use and functional status changes are important aspects of determining treatment success in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Bahng, Hye Hyun, Green, Stacey, Lai, Albert, Hu, Jethro, Green, Richard, Iwamoto, Fabio, Lassman, Andrew B, Cloughesy, Timothy, Nghiemphu, Phioanh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693034/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.074
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller